Status:

SUSPENDED

SCUBE-1 and Carotid Intima Media Thickness in Recurrent Pregnancy Loss

Lead Sponsor:

Recep Tayyip Erdogan University Training and Research Hospital

Conditions:

Recurrent Pregnancy Loss

Eligibility:

FEMALE

18-40 years

Brief Summary

Clinical research will be carried out on two groups of patients. It will be performed on people with recurrent pregnancy loss and without a history of pregnancy loss. In two groups, blood samples will...

Detailed Description

A total of 80 women who will apply to our obstetric clinic for early pregnancy loss or routine first trimester prenatal care will be included in the study. Patients will be divided into two groups. In...

Eligibility Criteria

Inclusion

  • Patients with a history of two or more unexplained first trimester miscarriages Healthy women attending for antenatal care with at least one previous uneventful natural pregnancy.
  • Women with normal pregnancy outcome and no previous pregnancy loss.

Exclusion

  • No occurrence of hypertensive or diabetic disease of pregnancy. Pregnancies beyond the first trimester will be excluded from the study Pre-existing diabetes Vascular disease Antiphospholipid syndrome (APS) Genetic abnormality(chromosomal anomaly) Anatomic disorder Endocrinologic disorder Autoimmunologic disorder Ischemic diseases Diabetes mellitus Heart disease Hypertension Medical condition Multiple pregnancy Fetal anomaly current smokers

Key Trial Info

Start Date :

May 22 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 23 2022

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04397042

Start Date

May 22 2020

End Date

June 23 2022

Last Update

May 12 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Recep Tayyip Erdogan University Faculty of Medicine, Department ofDepartment of Obstetrics and Gynecology

Rize, Turkey (Türkiye), 53200